12th Summit on Biosimilars & Innovator Biologics

 12th Summit on Biosimilars & Innovator Biologics

12th Summit on Biosimilars & Innovator Biologics

June 22 – 23, 2021 (EDT) | Virtual Conference

The American Conference Institute invites you to attend the Virtual 12th Summit on Biosimilars & Innovator Biologics on June 22-23, 2021! Gain government and industry insights on the Innovator and Biosimilars Marketplace from the U.S. FTC, U.S. FDA, USPTO, and leading In-House Counsel.

As the number of FDA-approved biosimilar products continues to grow, the need for a solid guiding framework becomes more critical than ever before. While the stakeholders wait for finality on the rules governing significant matters like interchangeability, substitution, and equivalency, it is clear that biosimilars will remain a top priority for the FDA.

The biosimilars market continues to maintain momentum as we head into 2021, but questions remain as to whether the U.S. market will catch up with Europe and whether biosimilars will provide their intended cost-savings.

Join the “Who’s Who” of the biosimilars and innovator biologics industries as they contemplate these and other probing questions.

View the full agenda, watch a free session and register today!

PharmaShots Readers SAVE 10% with registration code: D10-658-658EX03

Online: https://bit.ly/3mUwE6o

Email: customerservice@americanconference.com

Phone: 1-888-224-2480

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post